| ||||
| ||||
Contact: European Respiratory Society Press Office
ERS@cedos.int.ch
41-22-827-3827
European Respiratory Society
St John's wort as effective as standard antidepressant
therapy
St John's wort is as effective as imipramine -
one of the most commonly used antidepressants - and should be considered as a
first line treatment in patients with mild to moderate depression, according to
the largest ever study of St John's wort published this week in the BMJ.
Contact: Emma Wilkinson
ewilkinson@bmj.com
44-20-7383-6529
BMJ-British Medical Journal
Plant compound blocks action of cancer genes
HHMI
researchers have found that a plant compound that produces severe neural defects
in developing embryos can block the action of mutated genes that produce basal
cell skin carcinomas, the most common form of human cancer.
Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
Dijon University Medical
Center
Contact: European Respiratory Society Press Office
ERS@cedos.int.ch
41-22-827-3827
European Respiratory Society
Dual drug treatment prevents formation of colon tumors in
mice
By combining an aspirin-like compound with a drug
that inhibits epidermal growth factor activity, HHMI scientists have nearly
eliminated pre-cancerous colon polyps in mice that are susceptible to developing
colon tumors. The strategy could become a powerful preventive therapy for human
colon cancer.
Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
First potential 'universal' cancer vaccine shows promise in
lab
Results from preliminary laboratory studies provide
the first functional evidence that developing a 'universal' cancer vaccine might
be possible, researchers from Duke University Medical Center and Geron Corp.
reported Tuesday.
Contact: Joanna Downer
downe010@mc.duke.edu
919-684-4148
Duke University
B cells may help maintain HIV infection
NIAID
scientists report for the first time that B cells - the antibody-producing cells
of the immune system - help ferry HIV throughout the blood and can likely
deliver the virus to nearby T cells. This discovery helps explain several
phenomena associated with HIV infection and paves the way for new approaches to
eliminating the virus from the blood.
Contact: Sam Perdue
sp189u@nih.gov
301-402-1663
NIH-National Institute of Allergy and
Infectious Diseases
Aerosol form of cyclosporine hits key cellular target in lung transplant
patients, researchers report at international meetin
An
aerosol spray that delivers the anti-rejection drug cyclosporine directly to
transplanted lungs targets an important biological process not seen with other
immunosuppressant drugs, including oral cyclosporine. Results from an ongoing
clinical study indicate aerosol cyclosporine hinders the pumping mechanism a
cell uses to spit out anything deemed undesirable, including drugs. National Institutes of
Health
Contact: Lisa Rossi
rossil@msx.upmc.edu
412-647-3555
University of Pittsburgh Medical
Center
|
